
Sign up to save your podcasts
Or


Award-winning researcher, Dr. Doruk Erkan joins us today with newly published classification criteria for Antiphospholipid Syndrome (APS). Dr. Erkan joins us today with those criteria and why he believes there is sufficient evidence to "Rethink APS".
By American College of Rheumatology4.9
6464 ratings
Award-winning researcher, Dr. Doruk Erkan joins us today with newly published classification criteria for Antiphospholipid Syndrome (APS). Dr. Erkan joins us today with those criteria and why he believes there is sufficient evidence to "Rethink APS".

498 Listeners

292 Listeners

131 Listeners

3,357 Listeners

1,145 Listeners

117 Listeners

121 Listeners

191 Listeners

146 Listeners

514 Listeners

368 Listeners

4 Listeners

183 Listeners

18 Listeners

6 Listeners